Felipe C Geyer

Felipe C Geyer

UNVERIFIED PROFILE

Are you Felipe C Geyer?   Register this Author

Register author
Felipe C Geyer

Felipe C Geyer

Publications by authors named "Felipe C Geyer"

Are you Felipe C Geyer?   Register this Author

80Publications

3064Reads

30Profile Views

Hyperactivation of MAPK Signaling Is Deleterious to RAS/RAF-mutant Melanoma.

Mol Cancer Res 2019 01 10;17(1):199-211. Epub 2018 Sep 10.

Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-18-0327DOI Listing
January 2019

The Spectrum of Triple-Negative Breast Disease: High- and Low-Grade Lesions.

Am J Pathol 2017 Oct 20;187(10):2139-2151. Epub 2017 Jul 20.

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2017.03.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809519PMC
October 2017

Reply to Rosen.

Mod Pathol 2017 10;30(10):1505-1506

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2017.70DOI Listing
October 2017

Genomic profiling of histological special types of breast cancer.

Breast Cancer Res Treat 2013 Nov 27;142(2):257-69. Epub 2013 Oct 27.

Division of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-013-2740-6DOI Listing
November 2013

14-3-3σ stabilizes a complex of soluble actin and intermediate filament to enable breast tumor invasion.

Proc Natl Acad Sci U S A 2013 Oct 25;110(41):E3937-44. Epub 2013 Sep 25.

Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1315022110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799319PMC
October 2013

Non-existence of caveolin-1 gene mutations in human breast cancer.

Breast Cancer Res Treat 2012 Jan 11;131(1):307-10. Epub 2011 Sep 11.

The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1761-2DOI Listing
January 2012

Molecular classification of estrogen receptor-positive/luminal breast cancers.

Adv Anat Pathol 2012 Jan;19(1):39-53

Department of Pathology, Hospital Israelita Albert Einstein, Instituto Israelita de Ensino e Pesquisa, São Paulo, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAP.0b013e31823fafa0DOI Listing
January 2012

Genomic analysis reveals the molecular heterogeneity of ovarian clear cell carcinomas.

Clin Cancer Res 2011 Mar;17(6):1521-34

Department of Gynaecologic Oncology, Royal Marsden Hospital NHS Foundation Trust, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, Royal Marsden Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-1688DOI Listing
March 2011

β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation.

Mod Pathol 2011 Feb 12;24(2):209-31. Epub 2010 Nov 12.

Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2010.205DOI Listing
February 2011

Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer.

Eur J Cancer 2011 Jan 9;47(1):138-50. Epub 2010 Sep 9.

Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London SW3 6JB, UK.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S095980491000788
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2010.08.007DOI Listing
January 2011

β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast.

Mod Pathol 2010 Nov 6;23(11):1438-48. Epub 2010 Aug 6.

The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/modpathol2010141
Publisher Site
http://dx.doi.org/10.1038/modpathol.2010.141DOI Listing
November 2010

Absence of microsatellite instability in mucinous carcinomas of the breast.

Int J Clin Exp Pathol 2010 Nov 27;4(1):22-31. Epub 2010 Nov 27.

Molecular Pathology Team, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016101PMC
November 2010

BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells.

Cell Stem Cell 2010 Sep;7(3):403-17

The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.stem.2010.07.010DOI Listing
September 2010

Breast cancer precursors revisited: molecular features and progression pathways.

Histopathology 2010 Aug 24;57(2):171-92. Epub 2010 May 24.

Molecular Pathology Team, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, 237 Fulham Road, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2559.2010.03568.xDOI Listing
August 2010

Genomic and immunohistochemical analysis of adenosquamous carcinoma of the breast.

Mod Pathol 2010 Jul 7;23(7):951-60. Epub 2010 May 7.

The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/modpathol201082
Publisher Site
http://dx.doi.org/10.1038/modpathol.2010.82DOI Listing
July 2010

A mouse model of melanoma driven by oncogenic KRAS.

Cancer Res 2010 Jul 1;70(13):5549-57. Epub 2010 Jun 1.

Signal Transduction Team, The Institute of Cancer Research, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-09-4254DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2896549PMC
July 2010

Histological types of breast cancer: how special are they?

Mol Oncol 2010 Jun 18;4(3):192-208. Epub 2010 Apr 18.

Cancer Research UK, London Research Institute, Lincoln's Inn Fields Laboratories, London WC2A 3PX, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2010.04.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527938PMC
June 2010

DNA amplifications in breast cancer: genotypic-phenotypic correlations.

Future Oncol 2010 Jun;6(6):967-84

The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, 237 Fulham Road, London SW36JB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.10.56DOI Listing
June 2010

Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type.

Mod Pathol 2009 Nov 24;22(11):1401-14. Epub 2009 Jul 24.

Division of Experimental Therapy, The Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2009.112DOI Listing
November 2009

Genetic characterization of breast cancer and implications for clinical management.

J Cell Mol Med 2009 Oct 14;13(10):4090-103. Epub 2009 Sep 14.

Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1582-4934.2009.00906.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496116PMC
October 2009

The role of molecular analysis in breast cancer.

Pathology 2009 Jan;41(1):77-88

The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00313020802563536DOI Listing
January 2009